Rhumbline Advisers ALDER BIOPHARMACEUTICALS INC C Transaction History

Rhumbline Advisers

  • $105 Billion
  • Q2 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 05, 2020
SELL
N/A
-115,142 Closed
0 $0
Q3 2019

Oct 23, 2019
BUY
N/A
6,988 Added 6.46%
115,142 $2.17 Million
Q2 2019

Aug 14, 2019
BUY
N/A
357 Added 0.33%
108,154 $1.27 Million
Q1 2019

May 01, 2019
BUY
N/A
10,035 Added 10.26%
107,797 $1.47 Million
Q4 2018

Jan 31, 2019
BUY
N/A
42,624 Added 77.3%
97,762 $1 Million
Q3 2018

Nov 07, 2018
SELL
N/A
-10,450 Reduced 15.93%
55,138 $918,000
Q2 2018

Aug 06, 2018
BUY
N/A
2,602 Added 4.13%
65,588 $1.04 Million
Q1 2018

May 02, 2018
BUY
N/A
1,540 Added 2.51%
62,986 $800,000
Q4 2017

Feb 09, 2018
SELL
N/A
-9,888 Reduced 13.86%
61,446 $704,000
Q3 2017

Nov 06, 2017
BUY
N/A
71,334
71,334 $874,000
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email